Boston Scientific Corporation
Boston Scientific Corporation’s Net Profit Margin at a glance
Boston Scientific Corporation reports net profit margin of 11.1% for Dec 2024. The prior period recorded 11.2% (Dec 2023). Year over year the metric moved −0.12 pts (−1%). The rolling three-period average stands at 9.3%. Data last refreshed Dec 18, 2025, 5:30 AM.
Latest reading
11.1% · Dec 2024
YoY movement
−0.12 pts (−1%)
Rolling average
9.3%
Current Net Profit Margin
11.1%
−0.12 pts
−1%
Rolling average
9.3%
Latest Value
11.1%
Dec 2024
YoY Change
−0.12 pts
Absolute
YoY Change %
−1%
Rate of change
3-Period Avg
9.3%
Smoothed
Narrative signal
Boston Scientific Corporation’s net profit margin stands at 11.1% for Dec 2024. Year-over-year, the metric shifted by −0.12 pts, translating into a −1% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How net profit margin shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports net profit margin of 11.1%. Assess earnings efficiency, margin resiliency, and profitability drivers using annual historical margins.
Monitoring margin quality
Expanding margins signal improved cost control or pricing power. Contracting margins can point to rising input costs, pricing pressure, or product mix shifts.
Pair margin with growth metrics
Combine margin trends with revenue growth to understand whether the company is scaling efficiently or sacrificing profitability for expansion.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s net profit margin profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current net profit margin?
As of Dec 2024, Boston Scientific Corporation reports net profit margin of 11.1%. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's net profit margin trending year over year?
Year-over-year, the figure shifts by −0.12 pts (−1%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does net profit margin matter for Boston Scientific Corporation?
Net profit margin measures how much of each dollar of revenue turns into net income after all expenses. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's net profit margin above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 9.3%. Comparing the latest reading of 11.1% to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's net profit margin refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 5:30 AM and updates automatically every 24 hours, keeping your valuation inputs current.